CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome
Vincent J. Guen(Centre National de la Recherche Scientifique), Pierre Colas(Centre National de la Recherche Scientifique), Aurélie Thollet(Institut du Thorax), Marc Flajolet(Rockefeller University), Sheila Unger(University of Lausanne), Carly Gamble(Centre National de la Recherche Scientifique), Yoan Ferandin(Centre National de la Recherche Scientifique), Laurent Meijer(ManRos Therapeutics (France)), Pascale A. Cohen(Lyon 1 Université), Andrea Superti‐Furga(University of Lausanne)
Cited by 87
Related Papers
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis
|Journal of Innate Immunity|2016|5k
Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease
|Journal of Biological Chemistry|2001|722
Nosology and classification of genetic skeletal disorders: 2010 revision
|American Journal of Medical Genetics Part A|2011|717
Nosology and classification of genetic skeletal disorders: 2019 revision
|American Journal of Medical Genetics Part A|2019|620
Nosology and classification of genetic skeletal disorders: 2015 revision
|American Journal of Medical Genetics Part A|2015|570